[HTML][HTML] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir, J Matras… - … journal of physiology …, 2012 - ncbi.nlm.nih.gov
… study, we evaluated the effects of dimebon upon β-amyloid (Aβ), tau and astrocytes in the
hippocampus of triple transgenic (3xTg-AD) mice, which develop AD-like pathology in an age-…

Chronic administration of Dimebon does not ameliorate amyloidpathology in 5xFAD transgenic mice

OM Peters, T Shelkovnikova… - Journal of …, 2013 - content.iospress.com
Dimebon did not result in amelioration of amyloid pathology, … In 3xTg-AD mice, which express
both mutant AßPP and tau … in coverage were seen in the hippocampus, we found cortical …

[HTML][HTML] Mitochondrial pharmacology of dimebon (latrepirdine) calls for a new look at its possible therapeutic potential in Alzheimer's disease

SH Eckert, J Gaca, N Kolesova, K Friedland… - Aging and …, 2018 - ncbi.nlm.nih.gov
… a transgenic mouse model expressing high ß-amyloid levels … but also in mouse cortex,
hippocampus and somewhat less the … indicating that dimebon restores changes of mitochondrial …

Novel sites of neuroprotective action of Dimebon (latrepirdine)

A Ustyugov, E Shevtsova, S Bachurin - Molecular neurobiology, 2015 - Springer
… patterns and changes in the nervous system of transgenic mice [18… Further, Dimebon-treated
animals had fewer amyloid deposits … might be linked with its ability to enhance hippocampal

New therapeutic property of Dimebon as a neuroprotective agent

A Ustyugov, E Shevtsova, GM Ashraf… - Current Medicinal …, 2018 - ingentaconnect.com
Dimebon on formation of pathological protein deposits by examining the disease pattern
development and changes in transgenic mice … level in primary rat hippocampal cells as well as …

Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice

MZ Kastyak-Ibrahim, DL Di Curzio, R Buist… - Magnetic resonance …, 2013 - Elsevier
changes in white matter between 3xTg-AD mice and controls, despite well-developed
neurofibrillary tangles and beta amyloidamyloid immunoreactive plaques in the hippocampus

[PDF][PDF] Gene dosage determines the behavioural phenotype in the 5xFAD mouse model of Alzheimer's disease: analysis of the contribution of brain insulin signalling …

D Medina-Vera, EN Zambrana-Infantes… - 2022 - scholar.archive.org
… HTZ and HZ mice exhibited hippocampal impairment caused … that amyloid plaques are
deposited in the hippocampalmouse models, such as 3xTg-AD, which exhibited changes

[HTML][HTML] Rodent models of amyloid-beta feature of Alzheimer's disease: Development and potential treatment implications

CH Poon, Y Wang, ML Fung, C Zhang… - Aging and disease, 2020 - ncbi.nlm.nih.gov
… : APP and PS1 genes, a 3xTg-AD mouse model was generated to … ) failed to alter hippocampal
BDNF levels in mice, but this … Drugs, such as Latrepirdine (Dimebon), which was shown to …

A bird's-eye view of the multiple biochemical mechanisms that propel pathology of Alzheimer's disease: recent advances and mechanistic perspectives on how to halt …

C Vegh, K Stokes, D Ma, D Wear… - Journal of …, 2019 - content.iospress.com
… levels of hippocampal TFEB and progress of AD pathology [43]. A … models of mice experience
behavioral changes as well with … that treatment of dimebon in AD transgenic mice lead to a …

Alzheimer's disease: the role of mitochondrial dysfunction and potential new therapies

ZL Hawking - Bioscience Horizons: The International Journal of …, 2016 - academic.oup.com
… for some of the classic pathological changes observed in … only been conducted in transgenic
mouse models and C elegans, … When dimebon was compared to a placebo group over a 6-…